All News

Lilly ICOS has launched a limited-time offer called "The Cialis Challenge," which offers to pay for a competing erectile dysfunction drug if a patient is not satisfied with tadalafil (Cialis).

The FDA has consolidated three existing areas within the Center for Drug Evaluation and Research to form the Office of Oncology Drug Products.

The California Medical Injury Compensation Reform Act (MICRA) has cut defendants' medical liability payments to winning plaintiffs by 30%, according to a study by RAND Corp., a nonprofit research organization.

Two investigational drugs-one for stress incontinence and one for overactive bladder-showed positive results in separate presentations at the International Consultation on Incontinence in Monte Carlo, Monaco.

Men whose PSA level increases by more than 2.0 ng/mL during the year prior to a prostate cancer diagnosis may have a relatively high risk of future cancer death even if they undergo radical prostatectomy, according to a recent report in the New England Journal of Medicine (2004; 351:125-35).

The Cleveland Clinic Glickman Urological Institute has established a new Minority Men's Health Center.

Judd W. Moul, MD, has been named chief of the division of urology at Duke University Medical Center in Durham, NC.

Even though most early-stage prostate cancers have a slow course, the cancers can become more aggressive and lethal in the long term, according to a study by Swedish researchers (JAMA 2004; 291:2713-9).

Chronic prostatitis equals high financial costs, according to research by the Chronic Prostatitis Collaborative Research Network (Arch Intern Med 2004; 164:1231-6).

Lexington, MA-Indevus Pharmaceuticals announced that trospium chloride (Sanctura) has been approved by the FDA for the treatment of overactive bladder with symptoms of urge incontinence, urgency, and urinary frequency.

We should be cautious in how we proceed in our attempts to advance this technology.

San Francisco--Stem cell therapy can repair the tissue damage that causes urinary incontinence, say Austrian researchers, who used myoblasts and fibroblasts to strengthen patients' rhabdosphincters and urethras and eliminate their symptoms.

Tracing technology can identify the precise location of the phone line your laptop is connected to.

Do you think the three available phosphodiesterase type-5 inhibitors-vardenafil hydrochloride (Levitra), tadalafil (Cialis), and sildenafil citrate (Viagra)-are essentially the same, or do they have distinct advantages in the treatment of ED?

The key advantage of the new markers is their ability to identify patients with low-grade 'nuisance' tumors.

GAO cites flaws in Medicare's policy for paying assistants-at-surgery, drawing ire of ACS and others.

Cancer is present in 15% of men with 'normal' PSAs and DREs; 2% have high-grade disease

Panel also suggests appropriate roles for combination therapy and SWL monotherapy

Studies show improved survival, longer time to progression with docetaxel-based therapy

Under our tax laws, the cost of land is a capital expense for which no tax deduction can be taken.

Ureteroscopy offers comparable stone-free rates to shock wave lithotripsy and percutaneous nephrolithotripsy in anomalous kidneys, according to researchers.

Stone burden significantly impacts procedure's stone-free rates and operative times.

Women given investigational agent show dry, improved outcomes more often than controls

In older patients, antidiuretic drug reduces nocturnal voiding by more than 50%

Alpha-blocker, PDE-5 combo doesn't lead to CV events

San Francisco--A commonly prescribed antibiotic and alpha-blocker appear to be ineffective in the treatment of men with moderate to severe chronic prostatitis/chronic pelvic pain syndrome of long duration. Results of a multicenter study found that both ciprofloxacin and tamsulosin-used primarily in the treatment of urinary tract infections and BPH, respectively-offered no significant benefit in the treatment of chronic prostatitis in patients who were heavily pretreated and had long-standing symptoms.

Sequential monotherapy yields poor results in CPPS

The Centers for Medicare & Medicaid Services and the National Cancer Institute have developed a joint Memorandum of Understanding to address how the two agencies can work together in five areas of technology, science, and patient care for cancer.